lobbying_activities: 3001363

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3001363	7cba4ccc-1b9c-4c89-99c7-2c6e1152a936	Q2	LUNGREN LOPINA LLC	401103314	AMPAC FINE CHEMICALS	2023	second_quarter	PHA	Fair treatment for US based pharmaceutical ingredients	Drug Enforcement Administration (DEA),HOUSE OF REPRESENTATIVES,SENATE	40000		0	0	2023-07-12T11:59:31-04:00